Showing 1961-1970 of 9108 results for "".
Core Marketing Philosophies and Your Practice
https://practicaldermatology.com/topics/practice-management/core-marketing-philosophies-and-your-practice/21032/The most successful practices treat formulas and strategies as loose parameters rather than hard-set rules to adhere to.The Future of Interleukin-based Therapy
https://practicaldermatology.com/topics/practice-management/the-future-of-interleukin-based-therapy/21133/IL inhibitors offer the promise of increased efficacy. Here is a snapshot view of current and investigational agents.How To Overcome “LCD” Planning in a Group Practice
https://practicaldermatology.com/topics/practice-management/how-to-overcome-lcd-planning-in-a-group-practice/21182/Concepts to be implemented to help you avoid LCD planning and address significant financial threats.Tips for dealing with patients and the media offered by Dr. Joel Schlessinger
https://practicaldermatology.com/topics/practice-management/tips-for-dealing-with-patients-and-the-media-offered-by-dr-joel-schlessinger/19155/In an increasingly connected world, business professionals must be aware of how negative customer experiences can quickly and easily be shared through the internet and social media. Dermatology is no different and Dr. Joel Schlessinger has heard of many cases in which a practice's reputation has sufVerrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/verrucous-psoriasis-a-rare-variant-refractory-to-topical-steroids/29204/In this case study, researchers present a patient with VP of the dorsal fingers that was initially diagnosed as psoriasis and treated with multiple topical steroids. Ultimately, the patient was refractory to steroid topical therapy and required consideration of alternative treatments for definitiveSystemic Corticosteroids, Chronic Inflammatory Skin Disease, and COVID-19: What Do We Know?
https://practicaldermatology.com/topics/infections-infectious-disease/systemic-corticosteroids-chronic-inflammatory-skin-disease-and-covid-19-what-do-we-know/23615/An assessment of the risk of COVID-19 infection imposed by systemic corticosteroid use in the setting of chronic inflammatory skin disease.Biologics in Psoriasis: The Next Generation
https://practicaldermatology.com/topics/psoriasis/biologics-in-psoriasis-the-next-generation/20807/Get familiar with the IL-23 monoclonal antibodies.2024 In Review: This Year's Trends in Dermatology
https://practicaldermatology.com/topics/feature/2024-review-years-trends-dermatology/29886/As the year comes to a close, Practical Dermatology asked Editorial Board members about trends from 2024—what was hot, what was not, new approvals that lived up to the hype, important new research, and other observations from the past year.How Will Dermatologists Use ChatGPT?
https://practicaldermatology.com/topics/practice-management/how-will-dermatologists-use-chatgpt/23876/Dr. Patel explores the potential role of ChatGPT in clinical practice and academics.On Dosage and Diet: Isotretinoin 101
https://practicaldermatology.com/topics/general-topics/on-dosage-and-diet-isotretinoin-101/21445/Isotretinoin is one of the most essential agents in the treatment of acne, but dietary and dosage considerations must be made to maximize efficacy. Author:Joshua Zeichner, MD